Noetik, an AI-driven biotech company focused on developing next-generation cancer therapies using self-supervised machine learning and high-throughput spatial data, has announced the release of a technical report on OCTO-VirtualCell (OCTO-vc).…
Mevion Medical Systems, a leader in compact proton therapy solutions, has announced that its MEVION S250i Proton Therapy System has received approval from the National Medical Products Administration (NMPA) of…
Life Line Screening, the nation’s top provider of preventive screenings, has introduced its new Mid-Year Health Check Screening. This mid-cycle biometric screening is designed to help individuals track their health…
Merz Therapeutics, part of the Merz Group and a leader in neurotoxin therapies, today announced that Health Canada has approved XEOMIN® (incobotulinumtoxinA) for the treatment of post-stroke lower limb spasticity…
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading biopharmaceutical provider in China, has announced the initiation of a Phase III clinical trial for its bivalent vaccine candidate,…
QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostic technologies for point-of-care settings, clinical labs, and transfusion medicine, announced the appointment of John R. Chiminski and R. Scott…
CVS Health Corporation (NYSE: CVS) has announced the results of its previously disclosed cash tender offer (the “Any and All Tender Offer”) for its 4.100% Senior Notes due 2025 (the…
Newron Pharmaceuticals S.p.A. has entered into a license agreement with EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., to develop, manufacture, and commercialize Newron’s innovative glutamate modulator, evenamide,…
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company focused on developing medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating cortisol, announced today that the primary endpoint…
Syncell, a leader in advanced subcellular protein purification and spatial proteomics analysis, has successfully closed a $15 million Series A funding round, bringing its total funding to $30 million. The…
MiSalud Health, a prominent digital health platform providing affordable, same-day bilingual (Spanish/English) telehealth consultations in both the United States and Mexico, has named co-founder Bismarck Lepe as the company’s new…
MiSalud Health, a prominent digital health platform offering affordable, same-day bilingual telehealth consultations (Spanish/English) in the U.S. and Mexico, has announced the appointment of co-founder Bismarck Lepe as CEO. Lepe…